Demiurge Technologies

Demiurge Technologies AG is a Swiss medical AI company focused on building clinical-grade precision aging and disease models. Demiurge's virtual patient platform is the world's first pharmaceutical AI platform to complete large-scale prospective public clinical validation (medRxiv: https://doi.org/10.1101/2022.03.14.22272372), demonstrating under the most stringent validation standards its ability to identify over 90% of indications that could bring clinical benefits for a new drug in the preclinical stage, and increase the clinical success rate of new drugs across all therapeutic areas by 10.4 times (from 7.9% to 82.0%).